Abstract
One of the factors required for successful retroviral transduction is contact between viral particles and target cells. We hypothesized that combining agents that improve virus–target cell interaction via different mechanisms will increase transduction efficiency. We examined the transduction efficiency of leukemic K562 cells, primary normal and chronic myelogenous leukemia CD34+ cells with the amphotropic retroviral vector, G1Na, packaged in PA317 by enumerating G418-resistant colonies in semisolid media. We evaluated the ability of the recombinant fibronectin fragment, CH296, cationic lipids, or a transwell flow-through system, alone or in combination to improve retroviral transduction. Transduction of K562 cells improved 1.5 to two-fold with lipids or CH296, while their combination improved transduction 2.5-fold. Transduction of K562 cells in the transwell flow-through system improved transduction three-fold. Transduction of normal (NL) CD34+ CFC improved 10-fold with lipids and 20-fold with CH296. Lipid and CH296 had synergistic effects. The transwell flow-through system improved transduction of normal CD34+ CFC 30-fold. Finally, similar to what was seen for K562 cells, transduction of CML CFC improved two- to three-fold with either CH296 or lipids, whereas the combination had synergistic effects. We conclude that any physical means that enhances contact between viral particles and target cells improves transduction. Two such methods that have different action mechanisms have additive or synergistic effects on transduction.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Havenga M, Hoogerbrugge P, Valerio D, van Es HH . Retroviral stem cell gene therapy Stem Cells 1997 15: 162–179
Chu P, Lutzko C, Steward A, Dube ID . Retrovirus-mediated gene transfer into human hematopoietic stem cells J Molec Med 1998 76: 184–192
Richardson C, Bank A . Developmental-stage-specific expression and regulation of an amphotropic retroviral receptor in hematopoietic cells Molec Cell Biol 1996 16: 4240–4247
Andreadis ST, Palsson BO . Moloney murine leukemia virus-derived retroviral vectors decay intracellularly with a half-life in the range of 5.5–7.5 hours J Virol 1997 71: 7541–7548
Palsson B, Andreadis S . The physico-chemical factors that govern retrovirus-mediated gene transfer Exp Hematol 1997 25: 94–102
Chuck AS, Clarke MF, Palsson BO . Retroviral infection is limited by Brownian motion Hum Gene Ther 1996 7: 1527–1534
Bagnis C, Chischportich C, Imbert AM, Van den Broeke A, Cornet V, Mannoni P . Efficiency of retroviral transduction into hematopoietic cells by cocultivation procedure does not correlate with viral titer Cancer Gene Ther 1997 4: 5–8
Forestell SP, Boehnlein E, Rigg RJ . Retroviral end-point titer is not predictive of gene transfer efficiency: implications for vector production Gene Therapy 1995 2: 723–730
Sekhar M, Kotani H, Doren S, Agarwal R, McGarrity G, Dunbar CE . Retroviral transduction of CD34-enriched hematopoietic progenitor cells under serum-free conditions Hum Gene Ther 1996 7: 33–38
Conneally E, Eaves CJ, Humphries RK . Efficient retroviral-mediated gene transfer to human cord blood stem cells with in vivo repopulating potential Blood 1998 91: 3487–3493
Hodgson CP, Solaiman F . Virosomes: cationic liposomes enhances retroviral transduction Nature Biotechnol 1996 14: 339–342
Kaneko Y, Tsukamoto A . Cationic liposomes enhance retrovirsus-mediated multinucleated cell formation and retroviral transduction Cancer Lett 1996 105: 39–44
Kaneko Y, Tsukamoto A . Structural characteristics of cationic liposomes with potent enhancing effect on retroviral transduction into human hepatoma cells Cancer Lett 1996 107: 211–215
Punzel M, Wissink SD, Miller JS, Moore KA, Lemischka IR, Verfaillie CM . The myeloid-lymphoid initiating cell (ML-IC) assay assesses the fate of multipotent human progenitors in vitro Blood 1999 93: 3750–3756
Cone RD, Mulligan RC . High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range Proc Natl Acad Sci USA 1984 81: 6349–6353
Lundell BI, McCarthy JB, Kovach NL, Verfaillie CM . Activation-dependent alpha5betal integrin-mediated adhesion to fibronectin decreases proliferation of chronic myelogenous leukemia progenitors and K562 cells Blood 1996 87: 2450–2458
Zhao RC, McIvor RS, Griffin JD, Verfaillie CM . Gene therapy for chronic myelogenous leukemia (CML): a retroviral vector that renders hematopoietic progenitors methotrexate-resistant and CML progenitors functionally normal and nontumorigenic in vivo Blood 1997 90: 4687–4698
Porter CD, Lukacs KV, Box G, Takeuchi Y, Collins MKL . Cationic liposomes enhance the rate of transduction by a recombinant retroviral vector in vitro and in vivo J Virol 1998 72: 4832–4840
Fasbender A, Zabner J, Chillon M, Moninger TO, Puga AP, Davison BL, Welsh MJ . Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo J Biol Chem 1997 272: 6479–6489
Hanenberg H, Xiao XL, Dilloo D, Hashino K, Kato I, Adachi A, Williams DA . Colocalization of retroviruses and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells Nature Med 1996 2: 876–882
Moritz T, Dutt P, Xiao X, Carstanjen D, Vik T, Hanenberg H, Williams DA . Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: evidence of direct viral binding to chymotryptic carboxyl-terminal fragments Blood 1996 88: 855–862
Ohneda O, Fennie C, Zheng Z, Donahue C, La H, Villacorta R, Cairns B, Lasky LA . Hematopoietic stem cell maintenance and differentiation are supported by embryonic aorta-gonad mesonephros region-derived endothelium Blood 1998 92: 908–919
Verfaillie CM . Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation Blood 1993 82: 2045–2053
Brandt JE, Galy AH, Luens KM, Travis M, Young J, Tong J, Chen S, Davis TA, Lee KP, Chen BP, Tushinski R, Hoffmann R . Bone marrow repopulation by human marrow stem cells after long-term expansion culture on a porcine endothelial cell line Exp Hematol 1998 26: 951–961
Acknowledgements
This work was supported by Grants RO1-DK-54037, RO1-CA-74887, RO1-CA-79955, PO1-CA-65493–01. We also acknowledge the support of the Bone Marrow Transplantation Research Fund and the Fairview Minnesota Hospital and Clinics. CMV is a scholar of the Leukemia Society of America.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Liu, H., Hung, Y., Wissink, S. et al. Improved retroviral transduction of hematopoietic progenitors by combining methods to enhance virus–cell interaction. Leukemia 14, 307–311 (2000). https://doi.org/10.1038/sj.leu.2401672
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2401672
Keywords
This article is cited by
-
A Microfluidic Device to Enhance Viral Transduction Efficiency During Manufacture of Engineered Cellular Therapies
Scientific Reports (2019)
-
Three-dimensional microenvironmental priming of human mesenchymal stem cells in hydrogels facilitates efficient and rapid retroviral gene transduction via accelerated cell cycle synchronization
NPG Asia Materials (2019)
-
SLAM-enriched hematopoietic stem cells maintain long-term repopulating capacity after lentiviral transduction using an abbreviated protocol
Gene Therapy (2010)
-
The FBMD-1 stroma cell line secretes a unique moiety which can increase retroviral transduction of lineage-committed and primitive human peripheral blood progenitor cells
Cancer Gene Therapy (2001)